Advertisement

Primäre ZNS-Lymphome

  • Martin GlasEmail author
  • Björn Scheffler
  • Sied Kebir
Living reference work entry
  • 2 Downloads
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Primäre ZNS-Lymphome sind aggressive Non-Hodgkin-Lymphome, die das Gehirnparenchym, die Meningen und das Rückenmark betreffen können.

Literatur

  1. Abrey LE, Batchelor TT, Ferreri AJM et al (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034–504Google Scholar
  2. Chamberlain MC (1994) Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer 73:1728–1730CrossRefGoogle Scholar
  3. Ekenel M, Iwamoto FM, Ben-Porat LS et al (2008) Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer 113(5):1025–1031CrossRefGoogle Scholar
  4. Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosee PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Ruda R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gorlov JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G, International Extranodal Lymphoma Study G (2016) Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol 3:e217–e227CrossRefGoogle Scholar
  5. Grommes C, DeAngelis LM (2017) Primary CNS Lymphoma. J Clin Oncol 35(21):2410–2418.  https://doi.org/10.1200/JCO.2017.72.7602. Epub 2017 Jun 22. ReviewCrossRefPubMedPubMedCentralGoogle Scholar
  6. Juergens A, Pels H, Rogowski S, Fliessbach K, Glasmacher A, Engert A, Reiser M, Diehl V, Vogt-Schaden M, Egerer G, Schackert G, Reichmann H, Kroschinsky F, Bode U, Herrlinger U, Linnebank M, Deckert M, Fimmers R, Schmidt-Wolf IG, Schlegel U (2010) Longterm survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Ann Neurol 67:182–189CrossRefGoogle Scholar
  7. Omuro A, Chinot O, Taillandier L, Ghesquieres H, Soussain C, Delwail V, Lamy T, Gressin R, Choquet S, Soubeyran P, Huchet A, Benouaich-Amiel A, Lebouvier- Sadot S, Gyan E, Touitou V, Barrie M, del Rio MS, Gonzalez-Aguilar A, Houillier C, Delgadillo D, Lacomblez L, Tanguy ML, Hoang-Xuan K (2015) Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial. Lancet Haematol 2:e251–e259CrossRefGoogle Scholar
  8. Pels H, Schmidt-Wolf IG, Glasmacher A, Schulz H, Engert A, Diehl V, Zellner A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Schaller C, Deckert M, Fimmers R, Helmstaedter C, Atasoy A, Klockgether T, Schlegel U (2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489–4495CrossRefGoogle Scholar
  9. Pels H, Juergens A, Schirgens I, Glasmacher A, Schulz H, Engert A, Schackert G, Reichmann H, Kroschinsky F, Vogt-Schaden M, Egerer G, Bode U, Deckert M, Fimmers R, Urbach H, Schmidt-Wolf IG, Schlegel U (2010) Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma [Epub vor Druck] Google Scholar
  10. Schäfer N, Glas M, Herrlinger U (2012) Primary CNS lymphoma: a clinician’s guide. Expert Rev Neurother 12(10):1197–1206.  https://doi.org/10.1586/ern.12.120CrossRefPubMedGoogle Scholar
  11. Schlegel U, Korfel A, Thiel E et al (2009) Primäre ZNS Lymphome. Onkologe 15:211–221CrossRefGoogle Scholar
  12. Shah GD, Yahalom J, Correa DD et al (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730–4735CrossRefGoogle Scholar
  13. Weller M, Martus P, Roth P, Thiel E, Korfel A, German PSG (2012) Surgery for primary CNS lymphoma? Challenging a paradigm. Neuro-oncol 14:1481–1484CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Abteilung Klinische Neuroonkologie, Klinik und Poliklinik für NeurologieUniversitätsklinikum EssenEssenDeutschland
  2. 2.DKFZ Abteilung Translationale Neuroonkologie am Westdeutschen TumorzentrumDKTK Partnerstandort Universitätsklinikum EssenEssenDeutschland
  3. 3.Abteilung Klinische Neuroonkologie, Klinik und Poliklinik für NeurologieUniversitätsklinikum EssenEssenDeutschland

Personalised recommendations